Mesenchymal Stem Cells: Biology and Therapeutic Applications
Mesenchymal Stem Cells (MSCs) are multipotent adult stem cells capable of differentiating into bone, cartilage, fat, and other connective tissue cell types. They are commonly isolated from bone marrow, adipose tissue, umbilical cord, and other adult tissues. MSCs possess strong immunomodulatory, anti-inflammatory, and regenerative properties, making them valuable candidates for cell-based therapies. Their ability to secrete bioactive molecules promotes tissue repair, angiogenesis, and wound healing. MSCs are being investigated in clinical trials for the treatment of orthopedic injuries, cardiovascular diseases, autoimmune disorders, neurological conditions, and inflammatory diseases. Advances in tissue engineering, biomaterials, and cell delivery systems are enhancing the therapeutic potential of MSCs. Ongoing research focuses on improving their long-term safety, survival, engraftment, and clinical efficacy while addressing regulatory challenges. Overall, mesenchymal stem cells represent a promising platform for advancing regenerative medicine and developing innovative treatments for a broad range of diseases.
Related Conference of Mesenchymal Stem Cells: Biology and Therapeutic Applications
19th World Congress on Advances in Stem Cell Research and Regenerative Medicine
19th International Conference on Human Genomics and Genomic Medicine
Mesenchymal Stem Cells: Biology and Therapeutic Applications Conference Speakers
Recommended Sessions
- Adult Stem Cells and Tissue-Specific Regeneration
- Cardiovascular Regeneration and Stem Cell Therapeutics
- Embryonic Stem Cells and Pluripotent Stem Cells
- Hematopoietic Stem Cell Transplantation
- Induced Pluripotent Stem Cells (iPSCs)
- Mesenchymal Stem Cells: Biology and Therapeutic Applications
- Orthopedic Regenerative Medicine and Bone Tissue Engineering
- Regenerative Medicine: Current Advances and Future Perspectives
- Stem Cell Biology and Cellular Mechanisms
- Stem Cell Therapy for Neurological Disorders
Related Journals
Are you interested in
- Adult Stem Cells and Tissue-Specific Regeneration - Regenerative Medicine_2026 (France)
- Advanced Gene Therapeutics - Cell Signaling 2026 (France)
- Artificial Intelligence and Computational Biology in Regenerative Medicine - Stemgen 2026 (Japan)
- Bioengineering Therapeutics - Cell Signaling 2026 (France)
- Biomaterials and Nanotechnology in Regenerative Medicine - Stemgen 2026 (Japan)
- Cancer Stem Cells and Oncology - Stemgen 2026 (Japan)
- Cardiovascular Regeneration - Stemgen 2026 (Japan)
- Cardiovascular Regeneration and Stem Cell Therapeutics - Regenerative Medicine_2026 (France)
- Cell Biology - Cell Signaling 2026 (France)
- Cell Culture and Bioprocessing - Cell Signaling 2026 (France)
- Cell Cycle/Proliferation - Cell Signaling 2026 (France)
- Cell Death and Viability - Cell Signaling 2026 (France)
- Cell Science and Stem Cell Research - Cell Signaling 2026 (France)
- Cellular Signaling - Cell Signaling 2026 (France)
- Cellular Therapies - Cell Signaling 2026 (France)
- Clinical Trials and Research in Stem Cell in Cancer Therapy - Cell Signaling 2026 (France)
- Clinical Trials and Translational Stem Cell Research - Stemgen 2026 (Japan)
- Embryonic Stem Cells and Pluripotent Stem Cells - Regenerative Medicine_2026 (France)
- Epidermis Stem Cell & Cancer Epidemiology - Cell Signaling 2026 (France)
- Ethical, Legal, and Social Implications in Stem Cell Research - Stemgen 2026 (Japan)
- Future Trends: Organoids, Bioengineering, and Next-Generation Therapies - Stemgen 2026 (Japan)
- Gene Editing and CRISPR Technologies - Stemgen 2026 (Japan)
- Hematopoietic Stem Cell Transplantation - Regenerative Medicine_2026 (France)
- Human Gene Therapy - Cell Signaling 2026 (France)
- Immunotherapy - Cell Signaling 2026 (France)
- Induced Pluripotent Stem Cells (iPSCs) - Regenerative Medicine_2026 (France)
- Induced Pluripotent Stem Cells (iPSCs) and Reprogramming - Stemgen 2026 (Japan)
- Mesenchymal Stem Cells (MSCs) in Therapy - Stemgen 2026 (Japan)
- Mesenchymal Stem Cells: Biology and Therapeutic Applications - Regenerative Medicine_2026 (France)
- Molecular Epigenetics - Cell Signaling 2026 (France)
- Nano-Therapy - Cell Signaling 2026 (France)
- Nanotechnology in Stem Cell - Cell Signaling 2026 (France)
- Orthopedic Regenerative Medicine and Bone Tissue Engineering - Regenerative Medicine_2026 (France)
- Regenerative Dentistry and Craniofacial Applications - Stemgen 2026 (Japan)
- Regenerative Medicine - Cell Signaling 2026 (France)
- Regenerative Medicine and Tissue Engineering - Stemgen 2026 (Japan)
- Regenerative Medicine: Current Advances and Future Perspectives - Regenerative Medicine_2026 (France)
- Regulatory and Ethical Issues of Therapies. - Cell Signaling 2026 (France)
- Stem Cell Banking and Cryopreservation - Stemgen 2026 (Japan)
- Stem Cell Biology and Cellular Mechanisms - Regenerative Medicine_2026 (France)
- Stem Cell Biology and Cellular Mechanisms - Stemgen 2026 (Japan)
- Stem Cell in Drug Development - Cell Signaling 2026 (France)
- Stem Cell Therapies - Cell Signaling 2026 (France)
- Stem Cell Therapy for Neurological Disorders - Regenerative Medicine_2026 (France)
- Stem Cells in Neurological and Neurodegenerative Disorders - Stemgen 2026 (Japan)
